Literature DB >> 23182879

Integrated regulation of autophagy and apoptosis by EEF2K controls cellular fate and modulates the efficacy of curcumin and velcade against tumor cells.

Yan Cheng1, Xingcong Ren, Yi Zhang, Yu Shan, Kathryn J Huber-Keener, Li Zhang, Scot R Kimball, Harold Harvey, Leonard S Jefferson, Jin-Ming Yang.   

Abstract

Endoplasmic reticulum (ER) stress induces both autophagy and apoptosis yet the molecular mechanisms and pathways underlying the regulation of these two cellular processes in cells undergoing ER stress remain less clear. We report here that eukaryotic elongation factor-2 kinase (EEF2K) is a critical controller of the ER stress-induced autophagy and apoptosis in tumor cells. DDIT4, a stress-induced protein, was required for transducing the signal for activation of EEF2K under ER stress. We further showed that phosphorylation of EEF2K at Ser398 was essential for induction of autophagy, while phosphorylation of the kinase at Ser366 and Ser78 exerted an inhibitory effect on autophagy. Suppression of the ER stress-activated autophagy via silencing of EEF2K aggravated ER stress and promoted apoptotic cell death in tumor cells. Moreover, inhibiting EEF2K by either RNAi or NH125, a small molecule inhibitor of the enzyme, rendered tumor cells more sensitive to curcumin and velcade, two anticancer agents that possess ER stress-inducing action. Our study indicated that the DDIT4-EEF2K pathway was essential for inducing autophagy and for determining the fate of tumor cells under ER stress, and suggested that inhibiting the EEF2K-mediated autophagy can deteriorate ER stress and lead to a greater apoptotic response, thereby potentiating the efficacy of the ER stress-inducing agents against cancer.

Entities:  

Keywords:  EEF2K; ER stress; apoptosis; autophagy; tumor cells

Mesh:

Substances:

Year:  2012        PMID: 23182879      PMCID: PMC3552884          DOI: 10.4161/auto.22801

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  35 in total

1.  Oncogenic B-RAF signaling in melanoma impairs the therapeutic advantage of autophagy inhibition.

Authors:  Jane L Armstrong; Marco Corazzari; Shaun Martin; Vittoria Pagliarini; Laura Falasca; David S Hill; Nicola Ellis; Salim Al Sabah; Christopher P F Redfern; Gian Maria Fimia; Mauro Piacentini; Penny E Lovat
Journal:  Clin Cancer Res       Date:  2011-01-26       Impact factor: 12.531

Review 2.  Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.

Authors:  Gökhan S Hotamisligil
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206.

Authors:  Yan Cheng; Xingcong Ren; Yi Zhang; Rajesh Patel; Arati Sharma; Hao Wu; Gavin P Robertson; Li Yan; Eric Rubin; Jin-Ming Yang
Journal:  Cancer Res       Date:  2011-02-09       Impact factor: 12.701

Review 4.  Targeting the endoplasmic reticulum-stress response as an anticancer strategy.

Authors:  Sandra J M Healy; Adrienne M Gorman; Parisa Mousavi-Shafaei; Sanjeev Gupta; Afshin Samali
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

5.  SP600125 negatively regulates the mammalian target of rapamycin via ATF4-induced Redd1 expression.

Authors:  Hyeon-Ok Jin; Sung-Keum Seo; Sang-Hyeok Woo; Eun-Sung Kim; Hyung-Chahn Lee; Doo-Hyun Yoo; Tae-Boo Choe; Seok-Il Hong; Jong-Il Kim; In-Chul Park
Journal:  FEBS Lett       Date:  2008-12-06       Impact factor: 4.124

Review 6.  Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities.

Authors:  Inki Kim; Wenjie Xu; John C Reed
Journal:  Nat Rev Drug Discov       Date:  2008-12       Impact factor: 84.694

7.  A critical role of eEF-2K in mediating autophagy in response to multiple cellular stresses.

Authors:  Bénédicte F Py; Michael Boyce; Junying Yuan
Journal:  Autophagy       Date:  2009-04-06       Impact factor: 16.016

8.  Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma.

Authors:  David S Hill; Shaun Martin; Jane L Armstrong; Ross Flockhart; Joge J Tonison; Dominic G Simpson; Mark A Birch-Machin; Christopher P F Redfern; Penny E Lovat
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

9.  Activating transcription factor 4 and CCAAT/enhancer-binding protein-beta negatively regulate the mammalian target of rapamycin via Redd1 expression in response to oxidative and endoplasmic reticulum stress.

Authors:  Hyeon-Ok Jin; Sung-Keum Seo; Sang-Hyeok Woo; Eun-Sung Kim; Hyung-Chahn Lee; Doo-Hyun Yoo; Sungkwan An; Tae-Boo Choe; Su-Jae Lee; Seok-Il Hong; Chang-Hun Rhee; Jong-Il Kim; In-Chul Park
Journal:  Free Radic Biol Med       Date:  2009-01-27       Impact factor: 7.376

10.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5.

Authors:  Kasper M A Rouschop; Twan van den Beucken; Ludwig Dubois; Hanneke Niessen; Johan Bussink; Kim Savelkouls; Tom Keulers; Hilda Mujcic; Willy Landuyt; Jan Willem Voncken; Philippe Lambin; Albert J van der Kogel; Marianne Koritzinsky; Bradly G Wouters
Journal:  J Clin Invest       Date:  2009-12-14       Impact factor: 14.808

View more
  27 in total

Review 1.  Therapeutic targeting of autophagy in disease: biology and pharmacology.

Authors:  Yan Cheng; Xingcong Ren; William N Hait; Jin-Ming Yang
Journal:  Pharmacol Rev       Date:  2013-08-13       Impact factor: 25.468

2.  Transforming growth factor-β1 up-regulates connexin43 expression in human granulosa cells.

Authors:  Yu-Ching Chen; Hsun-Ming Chang; Jung-Chien Cheng; Horng-Der Tsai; Cheng-Hsuan Wu; Peter C K Leung
Journal:  Hum Reprod       Date:  2015-07-22       Impact factor: 6.918

3.  Eukaryotic Extension Factor 2 Kinase may Affect the Occurrence and Development of Glioblastoma Through Immune Cell Infiltration.

Authors:  Lilan Cen; Qian Gu; Xinhong Zhou; Haishan Lu; Qian Yang
Journal:  Neurochem Res       Date:  2022-07-18       Impact factor: 4.414

4.  eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.

Authors:  Y Cheng; X Ren; Y Yuan; Y Shan; L Li; X Chen; L Zhang; Y Takahashi; J W Yang; B Han; J Liao; Y Li; H Harvey; A Ryazanov; G P Robertson; G Wan; D Liu; A F Chen; Y Tao; J-M Yang
Journal:  Oncogene       Date:  2016-05-16       Impact factor: 9.867

5.  Apoptosis and autophagy in polycystic kidney disease (PKD).

Authors:  Kristen L Nowak; Charles L Edelstein
Journal:  Cell Signal       Date:  2019-12-24       Impact factor: 4.315

6.  Transcriptomic Changes Associated with Loss of Cell Viability Induced by Oxysterol Treatment of a Retinal Photoreceptor-Derived Cell Line: An In Vitro Model of Smith-Lemli-Opitz Syndrome.

Authors:  Bruce A Pfeffer; Libin Xu; Steven J Fliesler
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 6.208

7.  Silencing of EEF2K (eukaryotic elongation factor-2 kinase) reveals AMPK-ULK1-dependent autophagy in colon cancer cells.

Authors:  Chuan-Ming Xie; Xiao-Yu Liu; Kathy W Y Sham; Josie M Y Lai; Christopher H K Cheng
Journal:  Autophagy       Date:  2014-06-19       Impact factor: 16.016

8.  eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancer.

Authors:  Ruo-Xi Wang; Xiao-En Xu; Liang Huang; Sheng Chen; Zhi-Ming Shao
Journal:  Ann Transl Med       Date:  2019-12

Review 9.  Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target.

Authors:  Didem Karakas; Bulent Ozpolat
Journal:  J Mol Med (Berl)       Date:  2020-05-07       Impact factor: 4.599

10.  Inhibition of elongation factor-2 kinase augments the antitumor activity of Temozolomide against glioma.

Authors:  Xiao-Yuan Liu; Li Zhang; Jianping Wu; Lei Zhou; Yi-Jie Ren; Wei-Qiong Yang; Zi-Jun Ming; Bo Chen; Jianrong Wang; Yi Zhang; Jin-Ming Yang
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.